Dominic R. Cundari

Insider Reports History

Location
Minneapolis, MN
Signature
/s/ Amy E. Culbert, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dominic R. Cundari:

Company Role Class Num Shares Value Price $ Report Date Ownership
DiaMedica Therapeutics Inc. Chief Commercial Officer Voting Common Shares, no par value per share 2,800 $7,840 $2.80 01 Jun 2024 Direct
DiaMedica Therapeutics Inc. Chief Commercial Officer Stock Option (right to buy) 15,000 01 Jun 2024 Direct

Insider Reports Filed by Dominic R. Cundari

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DMAC DiaMedica Therapeutics Inc. 01 Jun 2024 1 $0 4 Chief Commercial Officer 03 Jun 2024, 16:58
DMAC DiaMedica Therapeutics Inc. 01 Jun 2023 1 $0 4 Chief Commercial Officer 02 Jun 2023, 17:01
DMAC DiaMedica Therapeutics Inc. 01 Feb 2022 2 $0 4 Chief Commercial Officer 02 Feb 2022, 15:45
DMAC DiaMedica Therapeutics Inc. 01 Feb 2022 0 $0 3 Chief Commercial Officer 02 Feb 2022, 15:37